Trump's MAHA Health Agenda Hits a Wall as CDC and Surgeon General Posts Remain Unfilled

Trump's Public Health Leadership Vacuum Is Growing — And It's Slowing the MAHA Agenda

Two of the federal government's most powerful public health roles remain without confirmed leaders, and the consequences are beginning to ripple through the Trump administration's signature "Make America Healthy Again" (MAHA) initiative.

The Centers for Disease Control and Prevention continues to operate without a Senate-confirmed director, while the president's nominee for U.S. Surgeon General, Casey Means, remains stuck in a Senate confirmation process that shows no signs of moving forward.

CDC Leaderless for Over 210 Days

The CDC has now surpassed 210 days without a Senate-confirmed director — a legally significant threshold, as federal law caps the amount of time an acting official can lead an agency. Despite this, the Trump administration has yet to put forward a permanent nominee.

The Department of Health and Human Services (HHS) confirmed that Secretary Robert F. Kennedy Jr. and Chris Klomp, who oversees Medicare and serves as a deputy administrator at the Centers for Medicare and Medicaid Services, are actively working alongside the White House to evaluate candidates capable of steering the CDC back to what the administration describes as its "original mission" of combating infectious disease.

The agency's most recent Senate-confirmed director, Susan Monarez, assumed the role in July but was dismissed in less than a month after reportedly clashing with Kennedy over vaccine policy. Her departure triggered a broader exodus of senior public health officials, many of whom cited concerns about political interference and the erosion of scientific independence within the agency.

The instability at the CDC was further compounded by a shocking act of violence at its Atlanta headquarters, where a gunman who blamed the COVID-19 vaccine for his mental health struggles fatally shot a law enforcement officer.

Vaccine Authority in Question

With no permanent director in place, a significant legal question has emerged around vaccine policy. Under federal guidelines, only the CDC director holds the authority to formally approve vaccine recommendations issued by the Advisory Committee on Immunization Practices (ACIP). Stanford law professor Anne Joseph O'Connell has noted that, in the absence of a confirmed director, that authority effectively shifts to Secretary Kennedy.

The situation was further complicated earlier this month when a federal judge ruled that Kennedy's hand-selected vaccine advisory panel had been unlawfully constituted, invalidating several of their recent decisions — including recommendations against the latest flu and COVID-19 vaccines and the removal of the RSV vaccine from the infant immunization schedule.

Reports from the New York Times indicate that White House officials are struggling to identify a CDC director candidate who both shares the administration's policy vision and can withstand the rigors of Senate confirmation.

Surgeon General Nominee Casey Means Still Awaiting a Vote

Meanwhile, the administration's choice for the nation's top doctor is equally adrift. Casey Means testified before the Senate health committee more than a month ago, yet no vote has been scheduled — leaving the Surgeon General position vacant more than 320 days after Trump first announced her nomination in May of last year. Her original confirmation hearing was delayed when she went into labor just hours before she was set to appear.

Means, 38, presents an unconventional profile for the nation's top medical officer. A graduate of Stanford School of Medicine, she did not complete her surgical residency at Oregon Health and Science University and does not hold an active medical license or board certification. Her public profile is largely built around her work as a health influencer and prominent voice within the MAHA movement — a space she shares with her brother, Calley Means, who serves as a health advisor to the administration.

A Contentious Confirmation Hearing

Her Senate testimony drew sharp scrutiny. Means sidestepped direct questions on vaccine guidance, attributed much of the country's chronic disease burden to environmental and lifestyle factors, and downplayed concerns about her limited clinical background. Lawmakers also raised questions about potential conflicts of interest stemming from her promotion of wellness products on social media.

The path to confirmation hinges on a handful of critical Republican votes on the Senate health committee, particularly those of Senator Bill Cassidy of Louisiana and two moderate GOP senators — Susan Collins of Maine and Lisa Murkowski of Alaska. All three expressed reservations during the hearing, and both Collins and Murkowski have since indicated they remain undecided.

"These issues are important to me," Murkowski said following the hearing, noting that Kennedy had made specific assurances about vaccine policy during his own confirmation that she felt had not been honored.

Cassidy, who chairs the health committee and is a physician by training, had initially voted to confirm Kennedy as HHS secretary despite concerns over his anti-vaccine positions, after receiving assurances that Kennedy would not interfere with the ACIP's membership. Kennedy subsequently restructured the department and sidelined career public health professionals — a move that has left Cassidy in a politically precarious position.

Political Pressure Mounts on Republican Holdouts

Both Cassidy and Collins face re-election battles this cycle, injecting additional political sensitivity into their votes. Cassidy is navigating a primary challenge from Louisiana Congresswoman Julia Letlow, who has received Trump's endorsement and the backing of MAHA PAC, which has pledged $1 million toward defeating the incumbent senator.

On Thursday, Letlow took to social media to publicly pressure Cassidy, urging him to "stop blocking" Means's nomination. "For too long, Washington has protected a healthcare system that waits until people are sick, cashes in on chronic disease, and leaves families to pay the price," she wrote. "President Trump is trying to change that, and Casey Means is a major part of that fight."

Collins, meanwhile, faces the prospect of a competitive general election race against the eventual Democratic nominee in Maine.

Allies of the MAHA movement have been ramping up pressure on Republican holdouts. During a recent organizing call hosted by the political advocacy group MAHA Action — which the Guardian monitored — Senator Rand Paul, himself a member of the health committee, urged participants to contact Cassidy, Collins, and Murkowski directly.

"We should have voted long ago," Paul said on the call, adding that the three senators "have not been vocal in their support for her nomination." He further argued that those who oppose Means's confirmation should at minimum be prepared to go on record with their opposition.

What's at Stake for America's Public Health Infrastructure

The prolonged absence of confirmed leadership at both the CDC and the Office of the Surgeon General raises serious questions about the administration's capacity to execute its own health policy agenda. With legal challenges mounting, key officials departing, and Senate confirmations stalled, the MAHA initiative faces significant structural headwinds — even from within the Republican Party itself.